The precise pathophysiological mechanisms of myocardial edema-induced cardiac dysfunction remain poorly defined. However, numerous studies using various models have demonstrated both systolic and diastolic dysfunction linked to myocardial edema. Preload recruitable stroke work (PRSW), an index of myocardial contractility independant of preload and afterload, is found to be decreased in edematous hearts. This decrease in PRSW responds in a dose-dependant fashion to increases in myocardial water content. 2 Diastolic dysfunction in myocardial edema is seen as an increase in the isovolumic relaxation time constant (ô) 2 and an increase in myocardial stiffness (i.e. a decrease in compliance effecting both the active and passive phases of ventricular relaxation. These combined effects result in decreased Myocardial Edema Attenuation and Sphingosine-1-Phosphate cardiac output (CO): a 3.5% increase in myocardial water content decreases CO by 40% at a given preload. 3 Decreased ventricular compliance and increased water content may also reduce cardiac efficiency as myocytes are forced to contract against increased intra-myocardial/ interstitial pressures and as the mass (inertia) of the myocardium increases with increasing water content. Ultimately, myocardial edema increases cardiac energy requirements. 4 Moreover, edema may lead to myocardial ischemia as diffusion distances increase with expanding interstitial space 4 and as coronary vascular resistance is increased 5 with elevated interstitial pressures and the resulting capillary bed compression. Finally, myocardial edema may trigger interstitial cardiac fibrosis, 3 thus chronically impeding cardiac function.
Sphingosine-1-phosphate, a lysophospholipid acting at various endothelial differentiation gene (EDG) receptors, has been shown to increase endothelial barrier function in human pulmonary artery endothelial cells, reducing both inflammation, microvascular leak and ultimately producing a protective effect against pulmonary edema formation. 6 The increase in endothelial cell barrier function is mediated by the EDG1 (S1PR1) receptor. This S1P receptor induces cell-to-cell adherens junction formation, cell-toextracellular matrix focal adhesion formation and a resultant decrease in vascular permeability. 6 Since the EDG1 receptor is abundantly expressed in cardiac endothelial cells 7 we hypothesized that S1P would, similarly, be protective against edema formation in the myocardium.
Study Methods

Animals, Groups and Heart Harvest
Male Sprague-Dawley rats weighing 350-450 grams (Harlan, Indianapolis, IN) were housed in facilities at the University of Chicago until experimentation. Animals were randomized to control or treatment groups by coin toss.
Three experimental groups were used. One group served as a non-ischemic control (Control, n=3), another served as an ischemia-reperfusion control (IR, n=7) and a final group served as the treatment group (S1P, n=8).
Rats are anesthetized using sodium pentobarbital (30mg bolus). Rats were anesthetized, intubated through a tracheostomy and then heparinized (500 IU bolus) via the IVC. 3 minutes after the heparin bolus the heart is removed from the chest through a sternotomy incision and placed in cold KrebsHenseleit buffer.
Isolated Heart Prep and Working Heart Model
The aorta was cannulated and the hearts were perfused for 5 minutes in retrograde fashion (Langendorff prep) with a modified KrebsHenseleit solution (37°C, pH 7.4). The hearts were switched to antegrade flow (working heart prep) and perfused with modified KrebsHenseleit solution in a closed recirculating system at 37 °C. Fresh perfusate was given every 15 minutes. In the working heart prep, perfusate entered the cannulated left atrium at a pressure of 8 mmHg (preload), and passed into the left ventricle (LV) from which it was spontaneously ejected through the aortic cannula against a pressure of 80 mmHg (afterload) (Figure 1 ). After an equilibration period of 5 min, hearts were electrically paced at 290-320 BPM via the metal cannula in the left atrium (LA). Heart rate and left atrial, aortic systolic and aortic diastolic pressures were recorded. Cardiac output (flow into the LA) and aortic flow were also measured. Coronary flow was calculated at the difference between cardiac output and aortic flow. 
Experimental protocol
Control hearts were mounted on the perfusion apparatus in a Langendorff prep for a 10 minute initiation period. After 10 minutes in the Langendorff prep these hearts were switched into the working heart prep for the remainder of the experiment. IR hearts were mounted on the perfusion apparatus in the Langendorff prep for 10 minutes and were subsequently switched into the working heart prep, as with the Control group. After a 15 minute stabilization period in the working heart prep, however, the IR hearts received a retrograde 30mL bolus of perfusate over 3 minutes and were then subjected to global, no-flow ischemia for 20 minutes. Following the ischemic period, IR hearts were reperfused in the Langendorff prep for 5 minutes and then switched back into the working heart prep for the remainder of the experiment. S1P hearts followed a protocol identical to the IR hearts, however the 30mL bolus of perfusate administered to the S1P hearts prior to ischemia contained 10nM S1P (Sigma Chemical, St. Louis, MO). All experiments ended at systolic failure, defined as the loss of antegrade aortic flow. In the working heart prep hearts were paced at 290-320 BPM via the left atrium.
Quantification of Myocardial Edema
LV tissue samples were stained with H&E. The ratio of intracellular area to total area and the ratio of interstitial area to total area were measured using Chromavision ACIS software (Clarient, Aliso Viejo, CA).
Statistics
Data are presented as mean (SEM). Error bars on graphs indicate SEM. Either one-way or twoway ANOVA was used to compare differences among groups when appropriate. Student's ttest was used to compare two groups. Significance was taken at p < 0.05.
Results
Edema
Histological analysis of cardiac tissue showed increased extracellular area in the IR group compared to the Control group (p=0.12) and increased extracellular area in the S1P group compared to the Control group (p=0.12).
Additionally, the IR group had decreased intracellular area compared to the Control group (p=0.13), as did the S1P group (p=0.14). In relation to the IR group, the S1P group showed non-significant decreases in extracellular area (p>0.05) and increases intracellular area (p>0.05). produce a less pronounced decrease in postischemic cardiac output. The hyperemic response seen in the early reperfusion period abated within 30 minutes post-ischemia and coronary flow remained stable until 105 minutes post-ischemia. Functional recovery in both IR and S1P groups peaked at 45 minutes post-ischemia, followed by a steady decline in function until failure.
Discussion:
Our data show indications that S1P may act to decrease interstitial edema in cardiac tissue following ischemia-reperfusion injury. Increases in extracellular area indicate fluid collection within the interstitium. As the interstitial space expands, intracellular area (as a percentage of total area) decreases. Both of these effects are seen in the S1P group and the IR group. Moreover, these effects are more severe in the IR group compared to the S1P group. These measures show a consistent, albeit nonsignificant, tendency for S1P treated hearts to recover towards Control values. Moreover, the higher post-ischemic coronary flows (both during the hyperemic recovery period and throughout the experiment) in the S1P hearts compared to IR hearts may be an additional indicator of decreased edema in S1P treated hearts. As fluid collects in the myocardium, interstitial pressures rise causing an increase in vascular resistance (increased interstitial pressure compresses the microvasculature). Despite trends towards improved functionality of S1P treated hearts, definitive conclusions about functional differences are hindered by the differing baseline characteristics of the S1P and IR groups. Although coronary flows were nearly identical at baseline, S1P hearts had noticeably higher systemic flows (and, consequently, higher cardiac outputs) at baseline.
This study gives some indication that S1P may be acting to reduce post-ischemic edema formation in the heart. Despite the observed trends, significance was not obtained in our primary measures of edema and our hemodynamic data is confounded by baseline differences in systemic flows between S1P and IR hearts. While these experiments may have picked up on some faint signals of edema attenuation, more sensitive methods will be required to further clarify the role of S1P in myocardial edema.
Currently, we have altered some of our methods in order to re-examine our hypothesis. To measure microvascular permeability directly, we will use Evans-Blue dyed albumin to quantify colloid protein extravasation. We will also add albumin to our modified krebs-henseleit solution in order to avoid the use of a crystalloid perfusate. This should serve as a more sensitive marker of edema. Although sustained recovery of systemic flow is the most clinically relevant parameter, we will include hemodynamic measures that are more sensitive to myocardial edema (e.g. PRSW, dP/dt, tau, -dP/dt and LVEDP). Finally, instead of ending the experiments at systolic failure, we will use a standard endpoint relative to the end of ischemia, where functional differences are more pronounced.
